logo

Best Practice Evidences for Treating Alcohol Withdrawal Syndrome

   

Added on  2023-06-03

7 Pages3014 Words144 Views
 | 
 | 
 | 
Assessment 3
Introduction
Alcoholism is the most common form of substance abuse disorder
worldwide in which an individual engages in unhealthy consumption of
alcohol and the common symptoms include craving for alcohol, spending
lot of resource on alcohol consumption and experiencing temporary
blackouts (Mendoza, 2018). Another issue is that people who try to abstain
from alcohol starts developing alcohol withdrawal syndrome resulting in
added complications for affected individuals (Shu, Lin & Chang, 2015).Hence,
this topic interests me because clinical problem of alcohol withdrawal
creates additional risk and uncertainty in addiction cessation treatment.
As a registered nurse, I am also interested in identifying the best way to
address the problem so that I am able to manage complexities and
morbidities in patients with alcohol withdrawal (Berl et al., 2015). Hence,
using the principles of evidence based practice, I aim to critically evaluate
three best practice evidences that can give idea regarding the suitable
interventions to treat patients with alcohol withdrawal syndrome and find
it relevance with clinical expertise and patients values.
Best Evidence
Best Practice Level of
Evidence
Study
Design
In-text Citation in
CDU APA 6th
Format
To treat severe alcohol
withdrawal syndrome by
providing adjunctive drug
phenobarbital
Level 4 Retrospective
cohort study
design
Gashlin et al. (2015)
Use of dexmedetomidine
to treat alcohol
Level 4 Retrospective
study design
Frazee et al. (2014)
Best Practice Evidences for Treating Alcohol Withdrawal Syndrome_1

withdrawal
To provide nursing
education on community
hospital’s alcohol
withdrawal protocol.
Level 4 Retrospective
study design
Barrett et al. (2016)
Annotated Bibliography
Gashlin, L. Z., Groth, C. M., Wiegand, T. J., & Ashley, E. D. (2015). Comparison of
alcohol withdrawal outcomes in patients treated with benzodiazepines alone versus
adjunctive phenobarbital: a retrospective cohort study. Asia Pacific Journal of Medical
Toxicology, 4(1), 31-36. Retrieved from:
http://eprints.mums.ac.ir/7875/1/APJMT_Volume%204_Issue%201_Pages%2031-36.pdf
Level 4 (Retrospective cohort study)
Gashlin et al. (2015) revealed that the problem associated with high dose benzodiazepines
(BZDs) because of over-sedation effect on patient. In response to this problem, the author
suggested Phenobarbital (PBT) as an alternative option for the management of alcohol
withdrawal. The main purpose of research was to evaluate the effectiveness of PBT as an
adjunctive therapy for alcohol withdrawal treatment. The retrospective cohort study included
those patients who were treated either with BZD alone or BZDs with adjunctive PBT. In the
two groups, the CIWA score (Tool for alcohol withdrawal) was recorded 24 hours after first
dose and safety end points such as need for intubation, seizures, hemodynamic stability and
mortality was recorded in both groups of patients. The statistical analysis of research data gave
the indication that median duration of withdrawal symptoms of only 44 hours in the PBT-
adjunct group compared to 53 hours only in the BZD group. The conclusion from the results
was that PBT can be a safe alternative to BZDs for treatment of alcohol withdrawal patients.
Barrett, J., Jansen, M., Cooper, A., Felbinger, M., & Waters, F. (2016). Embracing a
nurse-driven alcohol withdrawal protocol through quality improvement. Journal of
addictions nursing, 27(4), 234-240. DOI: 10.1097/JAN.0000000000000142
Level 4(Retrospective cohort study)
The study by Barrett et al. (2016) gave an insight the importance of symptom triggered
protocols in decreasing alcohol withdrawal rate and problem of nurse’s non-compliance to
such protocols. The main aim of the study was to evaluate whether implementing educational
program can improve nursing compliance with alcohol withdrawal protocol or not. The
retrospective study was done in two stages. The first stage comprised conducting initial needs
assessment followed by nursing education and the second stage involved retrospective review
after education. Visual algorithm was used to simplify the alcohol withdrawal protocol and
guide nurses regarding the alcohol withdrawal pathway. The primary outcome of interest was
nurse’s compliance rate and secondary outcome included hospital stay and CIWA score for
assessment of alcohol withdrawal. The statistical analysis of research data revealed increase in
Best Practice Evidences for Treating Alcohol Withdrawal Syndrome_2

compliance of 1-hour assessment after the educational intervention. However, major difference
was not found for 6-hour assessment. The author concluded that nursing education has the
potential to improve compliance with alcohol withdrawal protocol, but future study must
evaluate the impact of assessment frequency intervals on patient outcomes.
Frazee, E. N., Personett, H. A., Leung, J. G., Nelson, S., Dierkhising, R. A., & Bauer, P.
R. (2014). Influence of dexmedetomidine therapy on the management of severe
alcohol withdrawal syndrome in critically ill patients. Journal of critical
care, 29(2), 298-302. Doi http://dx.doi.org/10.1016/j.jcrc.2013.11.016
Level 4 evidence (cross sectional cohort study)
Frazee et al. (2014) is a well-published research paper that introduced the problem associated
with the use of BZDs as a first line drug for alcohol withdrawal. The main concern was that
increasing the dose may lead to extra complications and little clinical benefits. The author
aimed to evaluate the efficacy of dexmedetomidine (a rapid onset and short duration of action
highly selective α2-adrenergic agonist) on affecting the hemodynamics of patients with alcohol
withdrawal. The retrospective analysis was done with critically ill patients with primary ICU
admission for alcohol withdrawal and treatment with dexmedetomidine. Incremental titration
was used to increase the desired depth of sedation. The clinical outcomes were assessed based
on CIWA-Ar score within 24 hours of admission. The study findings reveal that
dexmedetomidine decreased the need for BZDs in patient and enhances hemodynamic stability
in patients with alcohol withdrawal. The author concluded that use of dexmedetomidine along
with BZDs is effective treatment option for reducing adverse outcome and achieving symptom
control in patient.
Justifying the Evidence
Out of the three best practice evidence selected, the retrospective cohort
study by Barrett et al. (2016) was conducted in a 369 bed community hospital in the United
States. The strength of this research paper is that instead of just implementing the education
intervention, the author added a needs assessment element in the retrospective review. This
step helped to identify the level of training and knowledge gap of nurses as well as understand
the type of training or education needed by health care staffs. This type of methodology
increases the practical relevance of data as it considers daily challenges experienced by clinical
staffs while addressing any research topic. Gaspard and Yang (2016) recommends needs
assessment before implementing any educational program in order to guide the policy making
process related to training needs and the development of training programs for different level
of health care professionals. This is good strategy to address resource limitation and skills gaps
of health care staffs. By the use of needs assessment, several areas of improvement in the
treatment of alcohol withdrawal could be identified (Barrett et al., 2016). Based on needs
assessment process, important strategies like improving screening process, duration of CIWA
assessment and complying with treatment protocol was identified. Hence, this research is
Best Practice Evidences for Treating Alcohol Withdrawal Syndrome_3

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Nurses' Attitudes in Supporting Clients With Substance Misuse
|33
|9175
|25

Increased Self-Care Activities and Glycemic Control Rate in Relation to Health Education via Wechat Among Diabetes Patients: A Randomized Clinical Trial
|12
|3843
|20

QUALITY USE OF MEDICINES DOCX.
|5
|2383
|14

Assignment on Nursing Pharmacology
|5
|899
|65